NEWS | bunyavax

Zoeken

10 okt 20236 minuten om te lezen

CEPI expands partnership with WBVR to advance Rift Valley Fever vaccine

· CEPI to invest up to $25.9 million, with support from the EU, in trials in East Africa to assess a vaccine candidate against...

88 weergaven0 opmerkingen

Novel Rift Valley fever vaccine dosed in Phase I human trial

info177574

18 aug 20223 minuten om te lezen

Novel Rift Valley fever vaccine dosed in Phase I human trial

LARISSA consortium reaches milestone Novel Rift Valley fever vaccine dosed in Phase I human trial The first healthy volunteer was dosed...

152 weergaven0 opmerkingen

info177574

1 sep 20211 minuten om te lezen

CSO shift at BunyaVax

Per 31 Aug 2021 Jeroen Kortekaas resigned as CSO of BunyaVax. He has been CSO since September 2017. Jeroen will continue his career as...

194 weergaven0 opmerkingen

Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle

Jeroen Kortekaas

15 sep 20201 minuten om te lezen

Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle

Please find here our latest paper on the safety and efficacy of our veterinary Rift Valley fever vaccine: https://www.ncbi.nlm.nih.gov/pm...

94 weergaven0 opmerkingen

info177574

26 feb 20201 minuten om te lezen

CEO shift at BunyaVax

Per 31 December 2019, Jochem Bossenbroek resigns as CEO of BunyaVax. He has been CEO since September 2017. Carine Punt has been appointed...

579 weergaven0 opmerkingen

BunyaVax CEO on stage at Animal AgTech Innovation Summit

info177574

10 okt 20191 minuten om te lezen

BunyaVax CEO on stage at Animal AgTech Innovation Summit

On 29-30 September, the first Animal AgTech Innovation Summit was held in Amsterdam. The summit brought together 200 international...

77 weergaven0 opmerkingen

BunyaVax provides technology to develop a human Rift Valley Fever vaccine in a $12.5 million project

info177574

10 jul 20194 minuten om te lezen

BunyaVax provides technology to develop a human Rift Valley Fever vaccine in a $12.5 million project

BunyaVax provides technology to develop a human Rift Valley Fever vaccine in a $12.5 million project financed by CEPI BunyaVax is...

237 weergaven0 opmerkingen

Jochem Bossenbroek speaker at Investment Trends In Animal Health

info177574

17 jan 20191 minuten om te lezen

Jochem Bossenbroek speaker at Investment Trends In Animal Health

On the 17th of January 2019, Jochem will be one of the speakers at the live webinar Investment Trends in Animal Health. The webinar is...

52 weergaven0 opmerkingen

BunyaVax featured in 10 Dutch Breakthrough Technologies for 2018

info177574

28 sep 20181 minuten om te lezen

BunyaVax featured in 10 Dutch Breakthrough Technologies for 2018

On Thursday 27 September StartupDelta announced their overview of 10 Dutch Breakthrough Technologies for 2018. BunyaVax made it to the...

87 weergaven0 opmerkingen

Jochem Bossenbroek invited to speak at the World Agri-Tech Innovation Summit

info177574

22 aug 20181 minuten om te lezen

Jochem Bossenbroek invited to speak at the World Agri-Tech Innovation Summit

Jochem Bossenbroek, CEO of BunyaVax, has accepted the invitation to join a panel discussion at the World Agri-Tech Innovation Summit. The...

35 weergaven0 opmerkingen

Jeroen Kortekaas to present at the Immuno Valley Annual Conference

info177574

7 aug 20181 minuten om te lezen

Jeroen Kortekaas to present at the Immuno Valley Annual Conference

Jeroen Kortekaas, CSO of BunyaVax, is invited as session speaker at the Immuno Valley Annual Conference 2018. The event will take place...

69 weergaven0 opmerkingen

info177574

13 jun 20181 minuten om te lezen

BunyaVax featured in Wageningen World

The journal Wageningen World has published an article about BunyaVax in the second edition of 2018: "Vaccines within months instead of...

69 weergaven0 opmerkingen

Prestigious SME Instrument funding for BunyaVax

info177574

6 apr 20181 minuten om te lezen

Prestigious SME Instrument funding for BunyaVax

BunyaVax receives 50.000 euro from the European Commission (EC). The funding proposal of BunyaVax was selected out of hundreds of...

134 weergaven0 opmerkingen

BunyaVax wins innovation award in London

info177574

28 feb 20181 minuten om te lezen

BunyaVax wins innovation award in London

Last week BunyaVax has won the 2018 Innovation Showcase Award at Animal Health Investment Europe. The event, organized by Kisaco...

77 weergaven0 opmerkingen

BunyaVax to present at Animal Health Investment Summit

info177574

10 jan 20181 minuten om te lezen

BunyaVax to present at Animal Health Investment Summit

BunyaVax will present at the Animal Health Investment Summit in Londen that will take place on 20-21 Februari 2018. BunyaVax is one of...

74 weergaven0 opmerkingen

info177574

10 jan 20181 minuten om te lezen

BunyaVax receives 40k Take-off grant

BunyaVax has been awarded €40k under the NWO Take-off programme. The grant allows BunyaVax to determine the route to market for its swine...

106 weergaven0 opmerkingen

info177574

1 sep 20171 minuten om te lezen

Jochem Bossenbroek appointed as CEO

BunyaVax has appointed Jochem Bossenbroek MSc. MBA as CEO of the company. Jochem has extensive experience in the biotech sector, gained...

126 weergaven0 opmerkingen

Jeroen Kortekaas and Paul Wichgers Schreur announce vision for BunyaVax

info177574

26 jul 20172 minuten om te lezen

Jeroen Kortekaas and Paul Wichgers Schreur announce vision for BunyaVax

Prof. Jeroen Kortekaas PhD, CSO of BunyaVax, and Paul Wichgers Schreur PhD, COO of the company, share their vision on the future of...

115 weergaven0 opmerkingen

info177574

3 jul 20171 minuten om te lezen

Official launch of BunyaVax B.V.

Today, the biotech company BunyaVax B.V. was officially launched. Goal of the company is to commercialize novel proprietary vaccine...

92 weergaven0 opmerkingen